Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Sees Large Increase in Short Interest

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the recipient of a significant growth in short interest in January. As of January 31st, there was short interest totalling 151,400 shares, a growth of 209.6% from the January 15th total of 48,900 shares. Based on an average trading volume of 115,400 shares, the short-interest ratio is currently 1.3 days.

Tevogen Bio Price Performance

Shares of NASDAQ:TVGNW opened at $0.08 on Friday. Tevogen Bio has a 52 week low of $0.01 and a 52 week high of $0.28. The firm has a 50 day moving average of $0.07 and a 200 day moving average of $0.05.

Tevogen Bio Company Profile

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.